# Gemini Space Station, Inc.: financial statements, quarterly

GEMI · Nasdaq · CIK 2055592 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/gemi.md) · [Financials](/companies/gemi/financials.md) · [Filings](/companies/gemi/filings.md) · [Insiders](/companies/gemi/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/gemi/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [24.5](/filings/0002055592-25-000009.md) | [43.3 d](/filings/0002055592-26-000026.md) | [35.3](/filings/0002055592-26-000050.md) | [33.3](/filings/0002055592-26-000065.md) | [50.6](/filings/0002055592-25-000009.md) | [60.3 d](/filings/0002055592-26-000026.md) | [50.3](/filings/0002055592-26-000050.md) | [45.5](/filings/0002055592-26-000065.md) |
| Operating income | $m | [(52.3)](/filings/0002055592-25-000009.md) | [(28.7) d](/filings/0002055592-26-000026.md) | [(48.0)](/filings/0002055592-26-000050.md) | [(65.4)](/filings/0002055592-26-000065.md) | [(121)](/filings/0002055592-25-000009.md) | [(111) d](/filings/0002055592-26-000026.md) | [(94.2)](/filings/0002055592-26-000050.md) | [(76.9)](/filings/0002055592-26-000065.md) |
| Income tax | $m | [(1.0)](/filings/0002055592-25-000009.md) | [4.7 d](/filings/0002055592-26-000026.md) | [(5.0)](/filings/0002055592-26-000050.md) | [0.1](/filings/0002055592-26-000065.md) | [(1.2)](/filings/0002055592-25-000009.md) | [0.1 d](/filings/0002055592-26-000026.md) | [0.0](/filings/0002055592-26-000050.md) | [0.0](/filings/0002055592-26-000065.md) |
| Net income | $m | [(90.2)](/filings/0002055592-25-000009.md) | [(27.0) d](/filings/0002055592-26-000026.md) | [(149)](/filings/0002055592-26-000050.md) | [(133)](/filings/0002055592-26-000065.md) | [(160)](/filings/0002055592-25-000009.md) | [(141) d](/filings/0002055592-26-000026.md) | [(109)](/filings/0002055592-26-000050.md) | [(108)](/filings/0002055592-26-000065.md) |
| Diluted EPS | $ per share | [(18.33)](/filings/0002055592-25-000009.md) | not reported | [(30.34)](/filings/0002055592-26-000050.md) | [(27.08)](/filings/0002055592-26-000065.md) | [(6.67)](/filings/0002055592-25-000009.md) | not reported | [(0.93)](/filings/0002055592-26-000050.md) | [(0.89)](/filings/0002055592-26-000065.md) |
| Basic EPS | $ per share | [(18.33)](/filings/0002055592-25-000009.md) | not reported | [(30.34)](/filings/0002055592-26-000050.md) | [(27.08)](/filings/0002055592-26-000065.md) | [(6.67)](/filings/0002055592-25-000009.md) | not reported | [(0.93)](/filings/0002055592-26-000050.md) | [(0.89)](/filings/0002055592-26-000065.md) |

- Revenue: us-gaap:Revenues
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2022-12-31) | period not labelled (2023-12-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [32.8](/filings/0002055592-26-000026.md) | not reported | [38.6](/filings/0002055592-25-000009.md) | [42.8](/filings/0002055592-26-000026.md) | [39.2](/filings/0002055592-26-000050.md) | [51.1](/filings/0002055592-26-000065.md) | [487](/filings/0002055592-25-000009.md) | [252](/filings/0002055592-26-000065.md) | [216](/filings/0002055592-26-000050.md) | [189](/filings/0002055592-26-000065.md) |
| Current assets | $m | not reported | not reported | not reported | not reported | [1,388](/filings/0002055592-26-000026.md) | not reported | not reported | [2,142](/filings/0002055592-25-000009.md) | [1,606](/filings/0002055592-26-000065.md) | [1,334](/filings/0002055592-26-000050.md) | [1,328](/filings/0002055592-26-000065.md) |
| Total assets | $m | not reported | not reported | not reported | not reported | [1,594](/filings/0002055592-26-000026.md) | not reported | not reported | [2,338](/filings/0002055592-25-000009.md) | [1,802](/filings/0002055592-26-000065.md) | [1,522](/filings/0002055592-26-000050.md) | [1,503](/filings/0002055592-26-000065.md) |
| Current liabilities | $m | not reported | not reported | not reported | not reported | [1,349](/filings/0002055592-26-000026.md) | not reported | not reported | [1,665](/filings/0002055592-25-000009.md) | [1,240](/filings/0002055592-26-000065.md) | [1,047](/filings/0002055592-26-000050.md) | [1,022](/filings/0002055592-26-000065.md) |
| Total liabilities | $m | not reported | not reported | not reported | not reported | [1,855](/filings/0002055592-26-000026.md) | not reported | not reported | [1,685](/filings/0002055592-25-000009.md) | [1,261](/filings/0002055592-26-000065.md) | [1,066](/filings/0002055592-26-000050.md) | [1,034](/filings/0002055592-26-000065.md) |
| Shareholders' equity | $m | [(491)](/filings/0002055592-26-000026.md) | [(644)](/filings/0002055592-26-000026.md) | [(682)](/filings/0002055592-25-000009.md) | [(768)](/filings/0002055592-25-000009.md) | [(795)](/filings/0002055592-26-000065.md) | [(938)](/filings/0002055592-26-000065.md) | [(1,069)](/filings/0002055592-26-000065.md) | [654](/filings/0002055592-25-000009.md) | [541](/filings/0002055592-26-000065.md) | [456](/filings/0002055592-26-000065.md) | [468](/filings/0002055592-26-000065.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(4.6) d](/filings/0002055592-26-000026.md) | [(18.4)](/filings/0002055592-26-000050.md) | [(0.1) d](/filings/0002055592-26-000065.md) | [(61.7) d](/filings/0002055592-25-000009.md) | [(138) d](/filings/0002055592-26-000026.md) | [(54.4)](/filings/0002055592-26-000050.md) | [(51.4) d](/filings/0002055592-26-000065.md) |
| Capital expenditure | $m | [0.8 d](/filings/0002055592-26-000026.md) | [0.2](/filings/0002055592-26-000050.md) | [0.2 d](/filings/0002055592-26-000065.md) | [1.1 d](/filings/0002055592-25-000009.md) | [0.5 d](/filings/0002055592-26-000026.md) | [0.1](/filings/0002055592-26-000050.md) | [0.1 d](/filings/0002055592-26-000065.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | period not labelled (2024-09-30) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [4.9](/filings/0002055592-25-000009.md) | [4.9](/filings/0002055592-26-000050.md) | [4.9](/filings/0002055592-26-000065.md) | [23.9](/filings/0002055592-25-000009.md) | [117](/filings/0002055592-26-000050.md) | [121](/filings/0002055592-26-000065.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.